PR.co.nz

Online Press Release Service for New Zealand  
Submission, publication, distribution and promotion of New Zealand online press releases.
Submit Your Press Release


rosiglitazone Press Releases

Suspension of Avandia (rosiglitazone) from New Zealand market

The medicine for diabetes called rosiglitazone is to be withdrawn from the NZ market from April 2011 following saftey review that has found increased risk of cardiovascular issues.

Submitted by pr.co.nz

February 19th, 2011 at 11:34 am